Cintas (CTAS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Jan, 2026Executive summary
Fiscal Q1 2025 revenue reached $2.5 billion, up 6.8% year-over-year, with organic growth at 8.0% after adjusting for acquisitions, FX, and fewer workdays, driven by new business, product penetration, and price increases.
Net income increased 17.4% to $452 million, and diluted EPS rose 18.3% to $1.10, reflecting a recent four-for-one stock split.
All business divisions contributed to growth, with strong demand across healthcare, hospitality, education, and government verticals.
Operational excellence, technology investments, and supply chain initiatives drove margin expansion and efficiency.
Cash flow from operations grew 38.5% to $466.7 million; free cash flow reached $373.8 million.
Financial highlights
Gross margin rose 9.7% to $1.25 billion, reaching 50.1% of revenue, up 140 basis points year-over-year.
Operating income was $561 million (22.4% of revenue), up 12.1% year-over-year and a record high.
Uniform rental and facility services revenue grew 5.9% to $1.93 billion; First Aid and Safety Services revenue increased 12.2% to $292.6 million.
Net cash provided by operating activities was $466.7 million, up from $336.9 million in the prior year quarter.
Dividends paid totaled $157.9 million and share repurchases reached $614.8 million during the quarter.
Outlook and guidance
Fiscal 2025 revenue guidance raised to $10.22–$10.32 billion (6.5%–7.5% growth), with organic growth expected at 7.0%–8.1%.
Diluted EPS guidance increased to $4.17–$4.25 (10.0%–12.1% growth).
Effective tax rate expected at 20.4% for fiscal 2025; Q1 effective tax rate was 15.8%, down from 19.2% last year.
Net interest expense projected at $101 million, up from $95 million in fiscal 2024.
Guidance assumes no future acquisitions, constant FX, and no additional share buybacks.
Latest events from Cintas
- Record revenue, margin expansion, raised guidance, and UniFirst acquisition highlight strong results.CTAS
Q3 202625 Mar 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Record growth, margin expansion, and a four-for-one stock split highlight strong 2025 outlook.CTAS
Q4 20243 Feb 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Revenue and net income surged with margin gains and higher full-year guidance.CTAS
Q2 202510 Jan 2026 - Record revenue, margin expansion, and raised guidance highlight strong quarterly performance.CTAS
Q2 20267 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025